通过双向门德尔随机化分析,探索血清脂质谱和炎症性肠病之间的因果关系
Xiaoli Pang1, Huizhong Yang1, Mingyu Li2
1Department of Pediatric Gastroenterology, Children's Medical Center, The First Hospital of Jilin University, Changchun, Jilin, China.
eGastroenterology
|February 13, 2025
概括
这项研究发现,常见的血脂水平 (如胆固醇和甘油三) 与炎症性肠病 (IBD) 风险之间没有因果关系. 这些发现表明血清脂质不是IBD发展的危险因素.
科学领域:
- 遗传学 遗传学 是一个
- 胃肠病学 胃肠病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 患有炎症性肠病 (IBD) 的患者经常表现出脂质不良症.
- 血清脂质样本和IBD之间的确切因果关系仍未确定.
- 调查这些联系对于了解IBD病原体至关重要.
研究的目的:
- 调查关键血清脂质谱与发展IBD的风险之间的潜在因果关系.
- 阐明脂质代谢和IBD之间的相互作用的性质.
- 为了确定总胆固醇,甘油三,HDL-C,LDL-C,Apo A,Apo B,或Lp (a) 是否因果关系影响IBD风险.
主要方法:
- 采用了两个样本的孟德尔随机化 (MR) 分析.
- 使用了R包"TwoSampleMR"和"孟德尔随机化".
- 采用多种MR方法 (加权中位数,MR-PRESSO,MR Egger) 并通过独立的GWAS数据验证了发现.
主要成果:
- 所有应用的MR方法始终表明七个脂质指数 (TG,TC,HDL-C,LDL-C,Apo A,Apo B,Lp(a)) 和IBD (包括克罗恩氏病和性结肠炎) 之间的无因果关系.
- 独立的全基因组关联研究 (GWAS) 验证了这些无因果效应,证实了研究结果的可靠性.
- 没有证据表明脂质谱是IBD发病的因果风险因素.
结论:
- 该研究得出的结论是,没有一个研究的血清脂质指数似乎是IBD发展的重要风险因素.
- 需要进一步的研究来探索血清脂和IBD之间的潜在非线性因果关系.
- 目前的证据不支持IBD病因学中常见的脂质参数的直接因果作用.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
304
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
304
Inflammatory Bowel Disease I: Ulcerative Colitis
126
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
126
Chronic Bowel Disorders: Introduction
384
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
384
Inflammatory Bowel Disease II: Crohn's Disease
171
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
171
Inflammatory Bowel Disease IV: Pharmacological Management
99
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
99
Irritable Bowel Syndrome I: Introduction
231
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
231


